Markets:

Overview

News

Currencies

International

Treasuries

Monopar Therapeutics Inc. - Common Stock (NQ:MNPR)

97.12 -0.67 (-0.69%)

Streaming Delayed Price Updated: 4:00 PM EDT, Jul 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Monopar Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

What's Going On With Cancer-Focused Monopar Therapeutics Stock Today? ↗

February 22, 2024

Monopar Therapeutics soars 36% in premarket trading on robust volume. Exciting preclinical data reveals MNPR-101's potent anti-tumor efficacy in targeting uPAR-expressing cancers.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 22, 2024

Via Benzinga

Crude Oil Rises 1%; US Jobless Claims Fall To 201,000 ↗

February 22, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping around 300 points on Thursday. The Dow traded up 0.67% to 38,872.01 while the NASDAQ rose 2.36% to 15,949.22. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 22, 2024

Via Benzinga

Monopar Announces Promising Preclinical Data for its MNPR-101 Radiopharma Program Targeting Advanced Cancers

February 22, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

Recap: Monopar Therapeutics Q3 Earnings ↗

November 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 21, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 20, 2024

Via Benzinga

Crude Oil Moves Lower; Summit Therapeutics Shares Plummet ↗

February 20, 2024

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling over 200 points on Tuesday. The Dow traded down 0.18% to 38,557.86 while the NASDAQ fell 1.30% to 15,570.84. The...

Via Benzinga

Topics Stocks

Why Is Cancer Drug Focused Monopar Therapeutics Stock Trading Higher On Tuesday? ↗

February 20, 2024

Monopar Therapeutics surges 90% premarket with 3.94 million volume after HREC clearance for Phase 1 dosimetry trial (MNPR-101-Zr) in advanced cancers.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 20, 2024

Via Benzinga

Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 20, 2024

Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results.

Via Benzinga

Dow Dips Over 100 Points; US Leading Economic Index Falls In January ↗

February 20, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 1.5% on Tuesday. The Dow traded down 0.35% to 38,494.51 while the NASDAQ fell 1.51% to 15,537.95. The S&P 500...

Via Benzinga

Topics Stocks

Nasdaq Down 1%; Capital One Set To Buy Discover ↗

February 20, 2024

U.S. stocks traded lower this morning, with the Nasdaq Composite falling around 150 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.05% to 38,607.53 while the NASDAQ fell...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 20, 2024

Via Benzinga

Monopar Receives Clearance to Proceed with First-in-Human Phase 1 Trial of Novel Radiopharmaceutical MNPR-101-Zr in Advanced Cancers

February 20, 2024

From Monopar Therapeutics Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

January 12, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

January 11, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

December 29, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 16, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

November 13, 2023

Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.

Via Benzinga

Why StoneCo Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket ↗

November 13, 2023

StoneCo Ltd. (NASDAQ: STNE) shares rose in pre-market trading after the company reported upbeat results for its third quarter on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 13, 2023

Via Benzinga

Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments

November 09, 2023

MNPR-101 Radiopharma Program to Enter First-in-Human Studies Potentially As Early As December of This Year Camsirubicin Phase 1b Trial Efficacy and Safety Data Highlighted at the 2023 CTOS Annual...

From Monopar Therapeutics Inc.

Via GlobeNewswire

Why BEST Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

November 06, 2023

Gainers Carbon Revolution Public Limited (NASDAQ: CREV) shares surged 358% to $134.37 in pre-market trading after gaining 100% on Friday. The company’s stock began trading on Friday following merger...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

November 03, 2023

It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today!

Via InvestorPlace

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 01, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.